What are the key differences between ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) regarding definition, clinical presentation, and acute management?

STEMI vs NSTEMI: Key Differences

STEMI and NSTEMI differ fundamentally in their pathophysiology, ECG presentation, and urgency of management—STEMI requires immediate reperfusion within 90 minutes while NSTEMI allows for risk-stratified timing of intervention within 24-72 hours.

Definition and Pathophysiology

STEMI results from complete occlusion of an epicardial coronary artery with transmural myocardial injury 1, 2. The thrombus completely blocks blood flow, creating larger infarctions with higher early mortality and greater risk of cardiogenic shock 3.

NSTEMI typically involves partial or intermittent occlusion, transient thrombosis, or microembolization 1, 4. The coronary artery maintains some flow (though critically reduced), resulting in subendocardial rather than transmural injury 1.

ECG Criteria

STEMI Diagnosis Requires:

• ST-segment elevation ≥1 mm in ≥2 contiguous leads 2
• OR in leads V2-V3: ≥1.5 mm (women), ≥2.5 mm (men <40 years), ≥2.0 mm (men ≥40 years) 5
• OR new left bundle branch block with clinical context 2
• OR STEMI equivalents: true posterior MI, hyperacute T-waves, multilead ST-depression with ST-elevation in aVR 6, 2

NSTEMI Presentation Shows:

• ST-segment depression 2
• T-wave inversions 1
• Nonspecific or normal ECG changes 1
• Dynamic waxing/waning patterns reflecting intermittent occlusion 1

Critical caveat: The ECG may be initially nondiagnostic—repeat ECGs every 10 minutes for the first hour if clinical suspicion remains high 5.

Biomarker Distinction

Both require elevated cardiac troponin for MI diagnosis 6. Serial troponins at presentation and 3-6 hours distinguish NSTEMI from unstable angina 6. However, troponin elevation alone does not differentiate STEMI from NSTEMI—the ECG determines this classification 1, 2.

Acute Management: The Critical Difference

STEMI Management (Immediate Reperfusion)

Primary PCI is the preferred reperfusion strategy with these time goals 6, 2:

• First medical contact (FMC) to device time ≤90 minutes if presenting directly to PCI-capable hospital 6, 2
• FMC to device time ≤120 minutes if transfer required from non-PCI-capable facility 6
• Door-in-door-out (DIDO) time ≤30 minutes at referring hospital 6

Fibrinolytic therapy is indicated when 1, 6:

• Anticipated FMC-to-device time exceeds 120 minutes
• Door-to-needle time goal: <30 minutes 1
• No contraindications to fibrinolysis exist
• Consider pharmaco-invasive strategy (fibrinolysis followed by angiography within 24 hours) in resource-limited settings 5

Fibrinolysis is contraindicated in NSTEMI and may cause harm 1.

NSTEMI Management (Risk-Stratified Approach)

High-risk NSTEMI (GRACE score >140 or TIMI score >4) requires early invasive strategy within 24 hours 6. This contrasts sharply with STEMI's 90-minute window.

Intermediate-risk patients: Invasive strategy within 24-72 hours 6

Management priorities 1, 7:

• Antiplatelet therapy (aspirin, P2Y12 inhibitors)
• Anticoagulation (heparin, LMWH)
• Anti-ischemic therapy (beta-blockers, nitrates)
• Risk stratification using validated scores 6

Clinical Presentation Overlap

Common pitfall: Approximately 40% of patients with acute coronary occlusion present without ST-elevation (STEMI-negative OMI) 8. These patients experience significant delays to catheterization (median 437 minutes vs 41 minutes for STEMI) despite having similar adverse outcomes 8.

Key distinguishing features 1, 3:

• STEMI: More acute presentation, higher initial lactate, more cardiac arrest
• NSTEMI: Older patients, more comorbidities, more multivessel disease requiring CABG (33% vs 8%) 9

Outcomes and Prognosis

Early mortality: STEMI has higher in-hospital mortality due to larger infarct size and acute complications 3, 4

Long-term outcomes: By 6 months, mortality rates converge as NSTEMI patients experience more recurrent ischemic events 3, 10. After adjustment for baseline characteristics, 1-year outcomes are similar 10.

Reinfarction risk: Slightly higher in NSTEMI (3.4% vs 2.8%), though this difference disappears after adjusting for comorbidities and treatment patterns 10.

Practical Algorithm

Upon patient presentation with chest pain:

1. Obtain 12-lead ECG within 10 minutes 2

2. If ST-elevation present → STEMI pathway:

   • Activate catheterization lab immediately
   • Target FMC-to-device ≤90 minutes (or ≤120 if transfer needed)
   • If delays anticipated, give fibrinolytics within 30 minutes

3. If no ST-elevation but high suspicion → NSTEMI pathway:

   • Serial troponins (0 and 3-6 hours) 6
   • Calculate risk score (GRACE or TIMI) 6
   • High-risk: catheterization within 24 hours
   • Intermediate-risk: catheterization within 24-72 hours
   • Initiate antiplatelet, anticoagulation, anti-ischemic therapy

4. Watch for STEMI equivalents that require immediate reperfusion despite lacking classic ST-elevation 6, 2, 11

The fundamental principle: STEMI demands emergency reperfusion measured in minutes; NSTEMI allows hours for risk stratification and planned intervention 1, 6, 2.